ValiRx plc

LSE (GBp): ValiRx plc (VAL)

Last Price

0.78

Today's Change

+0.23 (41.81%)

Day's Change

0.606 - 0.875

Trading Volume

28,766,793

Overview

Market Cap

2 Million

Shares Outstanding

374 Million

Avg Volume

1,814,901

Avg Price (50 Days)

0.51

Avg Price (200 Days)

0.92

PE Ratio

-0.78

EPS

-0.01

Earnings Announcement

15-Sep-2025

Previous Close

0.55

Open

0.80

Day's Range

0.606 - 0.875

Year Range

0.375 - 3.5

Trading Volume

28,830,384

Price Change Highlight

1 Day Change

41.82%

5 Day Change

75.79%

1 Month Change

41.82%

3 Month Change

30.00%

6 Month Change

7.59%

Ytd Change

4.00%

1 Year Change

-70.00%

3 Year Change

-96.00%

5 Year Change

-90.55%

10 Year Change

-99.99%

Max Change

-100.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a small molecule that has completed Phase I/II trials for the treatment of prostate cancer and other hormone associated solid tumours comprising breast and ovarian cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer. Its drug candidates also comprise VAL301, a peptide ingredient that in pre-clinical development for the treatment of women with endometriosis; and BC201, a combination of the peptide ingredient of VAL201/VAL301 with complementary active components for the treatment for patients suffering severe symptoms of Covid-19. ValiRx plc was incorporated in 2000 and is based in Hatfield, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment